Risk factors for portopulmonary hypertension in patients with cirrhosis: a prospective, multicenter study-Reference-Cited by-同舟云学术

Risk factors for portopulmonary hypertension in patients with cirrhosis: a prospective, multicenter study

Published:2022-12-07 Issue:1 Volume:17 Page:139-149
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Atsukawa Masanori^ORCID,Tsubota Akihito,Kondo Chisa,Koyano Kaori-Shioda,Ishikawa Toru,Toyoda Hidenori,Takaguchi Koichi,Watanabe Tsunamasa,Matsuura Kentaro,Ogawa Chikara,Hiraoka Atsushi,Okubo Hironao,Tateyama Masakuni,Uojima Haruki,Nozaki Akito,Chuma Makoto,Kato Keizo,Mikami Shigeru,Tani Joji,Morishita Asahiro,Kawata Kazuhito,Tada Toshifumi,Furuichi Yoshihiro,Okubo Tomomi,Kawano Tadamichi,Arai Taeang,Kawabe Naoto,Kawamura Naohiro,Ikegami Tadashi,Nakamuta Makoto,Shigefuku Ryuta,Iwasa Motoh,Tanaka Yasuhito,Hatano Masaru,Iwakiri Katsuhiko

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

https://link.springer.com/content/pdf/10.1007/s12072-022-10456-y.pdf

Reference37 articles.

1. Salerno F, Gerbes A, Ginès P, et al. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut. 2007;56(9):1310–1318

2. Hervé P, Lebrec D, Brenot F, et al. Pulmonary vascular disorders in portal hypertension. Eur Respir J. 1998;11(5):1153–1166

3. Krowka MJ, Fallon MB, Kawut SM, et al. International liver transplant society practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension. Transplantation. 2016;100(7):1440–1452

4. Rodríguez-Roisin R, Krowka MJ, Hervé P, et al. ERS task force pulmonary-hepatic vascular disorders (PHD) scientific committee. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J. 2004;24(5):861–880

5. Savale L, Watherald J, Sitbon O. Portopulmonary hypertension. Semin Respir Crit Care Med. 2017;38(5):651–661

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Total bile acids levels as a stratification tool for screening portopulmonary hypertension in patients with decompensated cirrhosis;Hepatology Research;2024-05-23

2. Leberzirrhosen;Therapie-Handbuch - Gastroenterologie und Hepatologie;2024

3. Is pulmonary arterial hypertension associated with schistosomiasis distinct from pulmonary arterial hypertension associated with portal hypertension?;JHLT Open;2023-10

4. How do the 2022 European Society of Cardiology/European Respiratory Society guidelines modify the diagnosis of portopulmonary hypertension in patients with cirrhosis complicated by portal hypertension? A post hoc analysis;JGH Open;2023-07-20